sylvain giraud
A Brussels bureaucrat / @EU_Health and pharma policy / accessibility availability affordability of medicines / health systems resilience/ RT≠endorsement /🌈
Last synced from Twitter 15m ago
AIM calls for a Pharmaceutical Strategy shaped to ensure and promote solidarity and sustainable healthcare in the European Union - AIM mutual
AIM, the International Association of Mutual Benefit Societies, has articulated a set of recommendations to rebalance pharmaceutical markets in Europe. AIM calls for the European Pharmaceutical Strategy to be first and foremost a health strategy to...
sylvain giraud
AIM calls for a Pharmaceutical Strategy shaped to ensure and promote solidarity and sustainable healthcare in the European Union
38m
Time to act together: patients wait more than 6 times longer for access to new medicines in neighboring European countries
The yearly EFPIA Patients WAIT survey, developed with the support of IQVIA, has found that patients in neighboring countries can wait over 6 times as long for access to new medicines.Speaking about the publication of the survey and report, EFPIA...
Resurgence of COVID-19 observed in some EU countries, says EU disease centre
Several European countries have reported a resurgence of cases or large localised outbreaks of COVID-19, and there is still 'community transmission' in most EU/EEA countries, according to a report released on Thursday (2 June). The report called for...
COVID-19, a European project will study the use of convalescent plasma as a treatment - European Blood Alliance
To ensure the protection of EU public health by promoting best practices on collection and use The European Commission just[…]
Which drugs and therapies are proven to work, and which ones don't, for COVID-19?
During the last six months, news reports have mentioned dozens of drugs that may be effective against the new coronavirus. Here we lay out the evidence and reveal which ones are proven to work. Or not.
sylvain giraud
Which drugs and therapies are proven to work, and which ones don't, for COVID-19? theconversation.com/which-drugs-an… via @ConversationUS
4h
One U.K. trial is transforming COVID-19 treatment. Why haven’t others delivered more results?
Clinical study has been helped by a simple design, a centralized health care system, and lots of infections
sylvain giraud
One U.K. trial is transforming COVID-19 treatment. Why haven’t others delivered more results?
5h
U.S. Seeks Large-Scale Expansion of Blood-Plasma Collection for Covid-19
Federal health officials are in talks with the American Red Cross and blood organizations about ramping up the collection of blood plasma from recovered Covid-19 patients, in a large-scale effort to build supplies of the promising experimental...
sylvain giraud
Federal health authorities are asking the American Red Cross and other blood banks to collect as much convalescent-blood plasma as they can from recovered Covid-19 patients wsj.com/articles/u-s-s… via @WSJ
5h
Coronavirus, parte il progetto europeo su terapia al plasma
La Commissione Europea ha approvato "Support-E": "Una iniziativa pan-europea fondamentale per valutare il plasma da convalescente come terapia per i pazienti affetti da Covid-19"
French Medics Sue Over Mask, Equipment Shortages Amid Virus
A collective of French health care workers said Thursday it is seeking a broad legal inquiry into France’s failure to protect its members and their colleagues by providing adequate masks, gloves and other protective equipment as the coronavirus...
Médicaments : la France en quête de souveraineté | La Story
A l'exemple du Doliprane que le président Macron souhaite voir fabriquer en France, une relocalisation de la production de médicaments est-elle possible
sylvain giraud
Podcast Médicaments : la France en quête de souveraineté - La Story | Podcast avec Acast
18h
La pénurie de médicaments en France, cet autre risque sanitaire | Code source
sylvain giraud
Podcast La pénurie de médicaments en France, cet autre risque sanitaire - Code source | Podcast avec Acast
18h
Scandale du médicament Dépakine : la justice reconnaît la responsabilité de l’Etat
La justice a condamné l’Etat à indemniser trois familles dont les enfants sont lourdement handicapés après avoir été exposés in utero à cet antiépileptique vendu par Sanofi.
sylvain giraud
Scandale du médicament Dépakine : la justice reconnaît la responsabilité de l’Etat lemonde.fr/police-justice… via @lemondefr
27h
« Pour sortir de la compétition entre Etats, une souveraineté sanitaire européenne est nécessaire »
TRIBUNE. Tara Varma, directrice d’un think tank européen, propose le lancement d’une stratégie sanitaire cohérente au sein de l’Union européenne afin de mieux répondre à la pandémie.
Taking stock of OECD Health Systems in the face of Covid-19
Three questions to Francesca Colombo, Head of the Health Division at the OECD, for Institut Montaigne
New partnership aims to increase antimicrobial resistance data in 4 African nations
A new pilot program run by Pfizer, Wellcome, and the governments of Ghana, Kenya, Malawi, and Uganda aims to increase the surveillance of antimicrobial resistance. A lack of data on the scale of the issue globally is hindering efforts to fight it.
"Globale Zusammenarbeit ist schlicht eine Grundbedingung für erfolgreiche Pandemiebekämpfung."
Prof. Ilona Kickbusch gehört zu den weltweit führenden Experten im Bereich Public Health. Der Pandemieausbruch überraschte sie nicht. Ein Gespräch über die Kassandrarolle, über weibliche Regierungspolitik und wie die Pandemiepläne nun überarbeitet...
FDA issues COVID-19 vaccine guidance, setting 50% effectiveness threshold
In an immediately effective guidance issued Tuesday, the US Food and Drug Administration (FDA) sets its expectations for the development and licensure of vaccines to prevent coronavirus disease (COVID-19), including considerations for manufacturing,...
EU Pharmaceutical Strategy could be a lost opportunity if action is not taken now
In its current form, the pharma strategy roadmap lacks the necessary drivers of innovation to put Europe back at the forefront of medical discovery...
sylvain giraud
"the pharma strategy roadmap lacks the necessary drivers of innovation to put Europe back at the forefront of medical discovery", writes @efpia
31h